Financials Conduit Pharmaceuticals Inc.

Equities

CDT

US20678X1063

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 31/05/2024 BST 5-day change 1st Jan Change
3.04 USD +1.33% Intraday chart for Conduit Pharmaceuticals Inc. +7.04% -33.19%

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 - 331.3
Enterprise Value (EV) 1 - 328.1
P/E ratio - -51 x
Yield - -
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA - -
EV / FCF - -
FCF Yield - -
Price to Book - -735 x
Nbr of stocks (in thousands) - 72,814
Reference price 2 10.25 4.550
Announcement Date 11/07/23 16/04/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales - - -
EBITDA - - -
EBIT 1 -2.918 -3.086 -5.262
Operating Margin - - -
Earnings before Tax (EBT) 1 -3.657 -4.887 -0.535
Net income 1 -3.657 -4.887 -0.535
Net margin - - -
EPS - - -0.0892
Free Cash Flow - - -
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 11/07/23 11/07/23 16/04/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 0.75 2.01 -
Net Cash position 1 - - 3.24
Leverage (Debt/EBITDA) - - -
Free Cash Flow - - -
ROE (net income / shareholders' equity) - 61% 10.1%
ROA (Net income/ Total Assets) - - -91%
Assets 1 - - 0.588
Book Value Per Share - - -0.0100
Cash Flow per Share - - 0.0600
Capex - - -
Capex / Sales - - -
Announcement Date 11/07/23 11/07/23 16/04/24
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. CDT Stock
  4. Financials Conduit Pharmaceuticals Inc.